治疗性疫苗与癌症免疫疗法
Therapeutic Vaccines and Cancer Immunotherapy.
作者信息
Bhatt Darshak, Daemen Toos
机构信息
Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, PO Box 30 001, HPC EB88, 9700RB Groningen, The Netherlands.
出版信息
Vaccines (Basel). 2020 Oct 10;8(4):596. doi: 10.3390/vaccines8040596.
Abstract
Cancer immunotherapy and immunization are the next steps towards safe and effective cancer treatment [...].
摘要
癌症免疫疗法和免疫接种是迈向安全有效癌症治疗的下一步举措[……]。
相似文献
1
Therapeutic Vaccines and Cancer Immunotherapy.治疗性疫苗与癌症免疫疗法
Vaccines (Basel). 2020 Oct 10;8(4):596. doi: 10.3390/vaccines8040596.
2
Towards a therapeutic breast cancer vaccine: the next steps.迈向治疗性乳腺癌疫苗：后续步骤
Expert Rev Vaccines. 2005 Dec;4(6):831-41. doi: 10.1586/14760584.4.6.831.
3
Towards personalized, tumour-specific, therapeutic vaccines for cancer.为癌症的个体化、肿瘤特异性治疗性疫苗而努力。
Nat Rev Immunol. 2018 Mar;18(3):168-182. doi: 10.1038/nri.2017.131. Epub 2017 Dec 11.
4
5
Checkpoint inhibitors for cancer immunotherapy. Multiple checkpoints on the long road towards cancer immunotherapy.用于癌症免疫治疗的检查点抑制剂。癌症免疫治疗漫长道路上的多个检查点。
Immunol Cell Biol. 2015 Apr;93(4):323-5. doi: 10.1038/icb.2015.12. Epub 2015 Feb 17.
6
Towards Breast Cancer Vaccines, Progress and Challenges.迈向乳腺癌疫苗：进展与挑战
Curr Drug Discov Technol. 2019;16(3):251-258. doi: 10.2174/1570163815666180502164652.
7
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.乳腺癌中的辅助性HER2/neu肽癌症疫苗
Immunotherapy. 2015;7(11):1159-68. doi: 10.2217/imt.15.81. Epub 2015 Nov 16.
8
Combined Cancer Immunotherapy Against Aurora Kinase A.联合癌症免疫疗法对抗极光激酶A
J Immunother. 2016 May;39(4):160-70. doi: 10.1097/CJI.0000000000000120.
9
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.将下一代树突状细胞疫苗纳入当前癌症免疫治疗领域。
Trends Immunol. 2017 Aug;38(8):577-593. doi: 10.1016/j.it.2017.05.006. Epub 2017 Jun 10.
10
MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.基于 MUC1 的重组卡介苗疫苗作为乳腺癌免疫治疗的候选物。
Expert Opin Biol Ther. 2010 Jul;10(7):1037-48. doi: 10.1517/14712598.2010.485185.
引用本文的文献
1
Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies.基于多重流式细胞术的检测方法，用于定量分析免疫治疗引起的肿瘤和病毒相关抗体。
Front Immunol. 2022 Nov 16;13:1038340. doi: 10.3389/fimmu.2022.1038340. eCollection 2022.
2
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics.利用癌症疫苗激发免疫系统：从预防到治疗
Vaccines (Basel). 2022 May 21;10(5):816. doi: 10.3390/vaccines10050816.
3
Fibroblasts Influence the Efficacy, Resistance, and Future Use of Vaccines and Immunotherapy in Cancer Treatment.成纤维细胞影响癌症治疗中疫苗和免疫疗法的疗效、耐药性及未来应用。
Vaccines (Basel). 2021 Jun 10;9(6):634. doi: 10.3390/vaccines9060634.
4
Nanotechnology synergized immunoengineering for cancer.纳米技术协同免疫工程治疗癌症。
Eur J Pharm Biopharm. 2021 Jun;163:72-101. doi: 10.1016/j.ejpb.2021.03.010. Epub 2021 Mar 24.
5
Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy.免疫肿瘤学中的精密工具：用于癌症免疫治疗的合成基因电路
Vaccines (Basel). 2020 Dec 3;8(4):732. doi: 10.3390/vaccines8040732.
本文引用的文献
1
Engineering strategies to overcome the current roadblocks in CAR T cell therapy.克服 CAR T 细胞疗法当前障碍的工程策略。
Nat Rev Clin Oncol. 2020 Mar;17(3):147-167. doi: 10.1038/s41571-019-0297-y. Epub 2019 Dec 17.
2
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.肿瘤突变负荷可预测多种癌症类型免疫治疗后的生存情况。
Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.
3
Cancer immunoediting and resistance to T cell-based immunotherapy.癌症免疫编辑与 T 细胞免疫疗法抵抗。
Nat Rev Clin Oncol. 2019 Mar;16(3):151-167. doi: 10.1038/s41571-018-0142-8.
4
Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?癌症患者的免疫活性状态对治疗性树突状细胞疫苗接种策略有影响吗？
Vaccines (Basel). 2018 Nov 23;6(4):79. doi: 10.3390/vaccines6040079.
5
Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy.外泌体、其生物发生及其在细胞间通讯、肿瘤微环境和癌症免疫治疗中的作用。
Vaccines (Basel). 2018 Sep 26;6(4):69. doi: 10.3390/vaccines6040069.
6
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?癌症中的BDCA1 + CD14 +免疫抑制细胞，一个潜在的靶点？
Vaccines (Basel). 2018 Sep 19;6(3):65. doi: 10.3390/vaccines6030065.
7
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy.子宫内膜间质肉瘤：对其作为免疫治疗靶点潜力的重新审视。
Vaccines (Basel). 2018 Aug 25;6(3):56. doi: 10.3390/vaccines6030056.
8
Therapeutic Vaccines for Genitourinary Malignancies.用于泌尿生殖系统恶性肿瘤的治疗性疫苗
Vaccines (Basel). 2018 Aug 12;6(3):55. doi: 10.3390/vaccines6030055.
9
Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.腹膜转移瘤腹腔内免疫治疗的早期研究与最新进展
Vaccines (Basel). 2018 Aug 10;6(3):54. doi: 10.3390/vaccines6030054.
10
Next Generation Cancer Vaccines-Make It Personal!下一代癌症疫苗——个性化定制！
Vaccines (Basel). 2018 Aug 9;6(3):52. doi: 10.3390/vaccines6030052.
Zotero 插件